Trials / Conditions / TDP-43 Proteinopathies
TDP-43 Proteinopathies
6 registered clinical trials studyying TDP-43 Proteinopathies — 3 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | [18F]ACI-19626 PET in TDP-43 Proteinopathies NCT06891716 | AC Immune SA | EARLY_Phase 1 |
| Recruiting | Neurodegenerative Diseases Progression Markers (MARKERS-NDD) NCT06596746 | Casa di Cura San Raffaele Cassino | — |
| Recruiting | Effects of Long Term Ventilation Support on the Quality of Life of ALS Patients and Their Families NCT05744310 | Haukeland University Hospital | N/A |
| Completed | Dopaminergic Therapy for Frontotemporal Dementia Patients NCT04937452 | I.R.C.C.S. Fondazione Santa Lucia | Phase 2 |
| Completed | AMX0035 in Patients With Amyotrophic Lateral Sclerosis (ALS) NCT03127514 | Amylyx Pharmaceuticals Inc. | Phase 2 |
| Completed | COMPARATIVE EFFECTIVENESS OF MCI and DEMENTIA TREATMENTS IN A COMMUNITY-BASED DEMENTIA PRACTICE NCT02860338 | Clionsky Neuro Systems Inc. | — |